# US 2006/0185083 A1 · Reciprocating movement platform for the external addition of pulses to the fluid channels of a subject

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0185083 A1
- Document ID: US20060185083A1
- Status: Published application
- Kind: A1
- Application number: 10/566,872
- Filed: 2004-08-04
- Published: 2006-08-24
- Earliest claimed: 2003-08-04
- Assignees: Non-Invasive Monitoring Systems, Inc.
- Inventors: Marvin Sackner
- Web page: https://patentgrep.com/patent/US20060185083A1

## CPC

- A61H 1/006: {Apparatus for applying pressure or blows for compressive stressing of a part of the skeletal structure, e.g. for preventing or alleviating osteoporosis}
- A61G 7/0573: {with mattress frames having alternately movable parts (adjustable mattress frames A61G7/015)}
- A61H 2201/0142: Beds
- A61H 2203/0456: Supine
- A61H: PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY (electrotherapy, magnetotherapy, radiation therapy or ultrasound therapy A61N)
- A61G: TRANSPORT, PERSONAL CONVEYANCES OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS (appliances for aiding patients or disabled persons to walk A61H3/00); OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES (embalming corpses A01N1/00)

## Abstract

An apparatus comprising a mattress, a mattress support, cast shoes, a footboard support, a drive for causing the reciprocating movement, and a box frame to contain and support the reciprocating movement platform is disclosed. The apparatus provides medical treatments, which are also described, by externally applying periodic acceleration to the body of a subject on the mattress.

## Claims

### Claim 1

A motion platform for providing periodic acceleration to a subject, comprising:
a box frame providing a foundation of the motion platform, said box frame having four wheel tracks located substantially at the four corners of the top portion of the box frame;
a drive module having four track wheels located substantially at the four corners of the top portion of the drive module, wherein said track wheels extend from the top portion of the drive module and rest in the wheel tracks of the box frame, whereby the drive module sits within the box frame and is operably movable relative to said box frame;
a support connected to said drive module, said support comprising:
a planar surface for supporting the subject, said planar surface having a head end and a foot end; and
a footboard connected at the foot end of the planar surface, said footboard rising perpendicularly to the planar surface and having cast shoes for securing the feet of the subject to the support; and
a motor secured to said box frame and connected to said drive module for providing periodic acceleration to the subject by moving in a line parallel to the planar surface of the support while the subject is secured to said support by said cast shoes on said footboard, and the periodic acceleration is alternately in the direction of the head end, and the foot end, of the planar surface, whereby the motion platform adds pulses to the fluid filled channels of the body of the subject;
wherein the drive module is horizontally displaced a fixed distance.

### Claim 2 (depends on 1)

The motion platform of claim 1, wherein the movement of the drive module is substantially sinusoidal.

### Claim 3 (depends on 1)

The motion platform of claim 1, wherein the fixed displacement of the drive module is about 1 cm to 5 cm.

### Claim 4 (depends on 1)

The motion platform of claim 1, wherein the fixed displacement of the drive module is about 2.5 cm.

### Claim 5 (depends on 1)

The motion platform of claim 1, wherein the speed of the drive module is about 120 to 160 cycles per minute.

### Claim 6 (depends on 1)

The motion platform of claim 1, wherein the speed of the drive module is about 140 cycles per minute.

### Claim 7 (depends on 1)

The motion platform of claim 1, wherein the movement of the drive module has a force in a range of about 0.1 g to about 0.4 g.

### Claim 8 (depends on 1)

The motion platform of claim 1, wherein the movement of the drive module has a force in a range of about 0.15 g to about 0.2 g.

### Claim 9 (depends on 1)

The motion platform of claim 1, wherein the motion platform is preset based on the size of the subject who will use the motion platform.

### Claim 10 (depends on 9)

The motion platform of claim 9, wherein the subject is obese and the motion platform is preset such that the movement of the drive module has a force of about 0.17 g.

### Claim 11 (depends on 9)

The motion platform of claim 9, wherein the subject has normal body weight and the motion platform is preset such that the movement of the drive module has a force of about 0.17 g.

### Claim 12 (depends on 1)

The motion platform of claim 1, wherein the motion platform also serves as a bed.

### Claim 13 (depends on 1)

The motion platform of claim 1, wherein the motion platform also serves as a sofa.

### Claim 14 (depends on 1)

The motion platform of claim 1, wherein the planar surface of the support can fit more than one subject.

### Claim 15 (depends on 1)

The motion platform of claim 1, wherein the motor has a shaft which produces rotary motion, said rotary motion being converted to horizontal motion by a worm gear, said worm gear having an output shaft secured to the drive module to thereby provide horizontal displacement.

### Claim 16

A motion platform for providing periodic acceleration to a subject, comprising:
a box frame providing a foundation of the motion platform;
a drive module adjoining said box frame, said drive module operably movable relative to said box frame; and
a support connected to said drive module, said support comprising:
a planar surface for supporting the subject, said planar surface having a head end and a foot end; and
a footboard connected at the foot end of the planar surface, said footboard rising perpendicularly to the planar surface and having cast shoes for securing the feet of the subject to the support;
wherein said drive module provides periodic acceleration to the subject by moving in a line parallel to the planar surface of the support while the subject is secured to said support by said cast shoes on said footboard, and the periodic acceleration is alternately in the direction of the head end, and the foot end, of the planar surface, whereby the motion platform adds pulses to the fluid filled channels of the body of the subject.

### Claim 17 (depends on 16)

The motion platform of claim 16, wherein the provided periodic acceleration is used as a stand-alone treatment or in conjunction with other therapeutic and/or preventative modalities.

### Claim 18 (depends on 16)

The motion platform of claim 16, wherein the provided periodic acceleration is used to treat and/or to prevent cancers in tissues of the subject.

### Claim 19 (depends on 16)

The motion platform of claim 16, wherein the provided periodic acceleration causes release of nitric oxide from the vascular endothelium of the subject through activation of endothelial nitric oxide synthase (eNOS) which in turn suppresses nuclear factor kappa beta.

### Claim 20 (depends on 16)

The motion platform of claim 16, wherein the provided periodic acceleration serves as a means for preconditioning, conditioning and/or postconditioning tissues of the body of the subject.

### Claim 21 (depends on 20)

The motion platform of claim 20, wherein treatment with periodic acceleration before, during, or after athletic performance prevents and/or treats tissue damage, reduces systemic stress, increases athletic performance, and/or prevents/treats any of the problems caused by strenuous athletic activity.

### Claim 22 (depends on 20)

The motion platform of claim 20, wherein regular treatment with periodic acceleration as a regimen for the athlete prevents and/or treats tissue damage, reduces systemic stress, increases athletic performance, and/or prevents/treats any of the problems caused by strenuous athletic activity.

### Claim 23 (depends on 20)

The motion platform of claim 20, wherein pretreatment with periodic acceleration improves athletic performance by preconditioning a body tissue of the athlete.

### Claim 24 (depends on 20)

The motion platform of claim 20, wherein pretreatment with periodic acceleration mitigates skeletal muscular cramps and/or helps prevent muscle strains during an athletic event.

### Claim 25 (depends on 20)

The motion platform of claim 20, wherein pretreatment with periodic acceleration mitigates and/or helps prevent delayed onset muscular soreness (DOMS) and involuntary muscle cramps and spasms immediately following the athletic event and/or delayed until the sleeping hours.

### Claim 26 (depends on 20)

The motion platform of claim 20, wherein pretreatment with periodic acceleration is used to treat exercise-induced bronchospasm in an athlete.

### Claim 27 (depends on 20)

The motion platform of claim 20, wherein pretreatment with periodic acceleration helps to reduce and/or prevent susceptibility of athletes to viral and bacterial infections.

### Claim 28 (depends on 20)

The motion platform of claim 20, wherein the pretreatment, treatment, and/or post-treatment with periodic acceleration treats or prevents cramps, aches, soreness, spasms, and other maladies brought on by exercise and/or other athletic activity.

### Claim 29 (depends on 16)

The motion platform of claim 16, wherein treatment using periodic acceleration assists or replaces the use of corticosteroids and non-steriodal anti-inflammatory drugs (NSAIDs) in management of pain, injury, muscle soreness, strains, and contusions in athletes.

### Claim 30 (depends on 16)

The motion platform of claim 16, wherein the provided periodic acceleration causes release of nitric oxide from the vascular endothelium of the subject through activation of endothelial nitric oxide synthase (eNOS) that in turn scavenges reactive oxygen species thereby diminishing or eliminating oxidative stress.

### Claim 31 (depends on 16)

The motion platform of claim 16, wherein the periodic acceleration provided by a motion platform to the subject causes release of nitric oxide from the vascular endothelium of the patient through activation of endothelial nitric oxide synthase (eNOS) which in turn suppresses the activity of inducible nitric oxide synthase (iNOS).

### Claim 32 (depends on 31)

The motion platform of claim 31, wherein the periodic acceleration treats and/or prevents cramps, aches, soreness, spasms, and the like at least because the suppression of nuclear factor kappa beta diminishes IL-1beta, IL-6, tumor necrosis factor and other inflammatory cytokines and adhesion molecules.

### Claim 33 (depends on 31)

The motion platform of claim 31, wherein the periodic acceleration treats and/or prevents cramps, aches, soreness, spasms, and the like at least because the suppression of iNOS may diminish IL-1beta, IL-6, tumor necrosis factor and other inflammatory cytokines and adhesion molecules.

### Claim 34 (depends on 16)

The motion platform of claim 16, wherein treatments of periodic acceleration are used in weight control of the subject.

### Claim 35 (depends on 16)

The motion platform of claim 16, wherein treatments of periodic acceleration are used to ameliorate metabolic syndrome, to improve sports performance, and/or to improve skeletal muscle pathology associated with the cachexia of COPD and cancers in weight control of the subject.

### Claim 36 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to promote ventricular remodeling.

### Claim 37 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat and/or prevent atrial fibrillation.

### Claim 38 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat and/or prevent complications from coronary bypass surgery.

### Claim 39 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat and/or prevent obstructive sleep apnea syndrome commonly observed in patients with coronary artery disease.

### Claim 40 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat and/or prevent cognitive deficits, learning deficits, and/or behavioral abnormalities in early cognitive impairment.

### Claim 41 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat and/or prevent Alzheimer's disease, vascular dementias, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's chorea, Wilson's disease, suprabulbar palsy, and/or Tourette syndrome.

### Claim 42 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat and/or prevent cardiac allograft vasculopathy.

### Claim 43 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to promote angiogenesis in ischemic tissues.

### Claim 44 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to manage hereditary hemorrhagic telangiectasia.

### Claim 45 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat and/or prevent migraine.

### Claim 46 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat the inflammation attendant with prion diseases.

### Claim 47 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to manage the aging process.

### Claim 48 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to manage Sjogren's syndrome.

### Claim 49 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to manage the chronic phase of Lyme disease.

### Claim 50 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat Gulf War syndrome.

### Claim 51 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to improve mucocilary clearance and surfactant production, and to minimize lung damage associated with usual positive pressure mechanical ventilation.

### Claim 52 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat patients who have corticosteroid resistance and asthma or corticosteroid resistance and inflammatory bowel disease.

### Claim 53 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat chronic otitis media.

### Claim 54 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to promote nail regeration.

### Claim 55 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to in conjunction with cell free hemoglobin transfusion in order to treat and/or prevent a nitric oxide deficit.

### Claim 56 (depends on 16)

The motion platform of claim 16, wherein periodic acceleration is used to treat radiation injuries.

### Claim 57

A method of medical treatment of a subject comprising the step of:
providing periodic acceleration to a body of the subject in order to externally and non-invasively add pulses to the body's fluid-filled channels over the body's own pulse;
wherein the periodic acceleration is provided by a motion platform comprised of a support on a drive module held by, and operably movable relative to, a box frame, wherein the subject is set on the support, and wherein the drive module is moved relative to the box frame to provide periodic acceleration to the body of the subject.

### Claim 58 (depends on 57)

The method of claim 57, wherein a motor secured to said box frame moves the drive module to provide the periodic acceleration of the subject.

### Claim 59 (depends on 57)

The method of claim 57, wherein the provided periodic acceleration is used to treat and/or to prevent cancers in tissues of the subject.

### Claim 60 (depends on 57)

The method of claim 57, wherein the provided periodic acceleration serves as a means for preconditioning, conditioning and/or postconditioning tissues of the body of the subject.

### Claim 61 (depends on 60)

The method of claim 60, wherein treatment with periodic acceleration before, during, or after athletic performance prevents and/or treats tissue damage, reduces systemic stress, increases athletic performance, and/or prevents/treats any of the problems caused by strenuous athletic activity.

### Claim 62 (depends on 60)

The method of claim 60, wherein regular treatment with periodic acceleration as a regimen for the athlete prevents and/or treats tissue damage, reduces systemic stress, increases athletic performance, and/or prevents/treats any of the problems caused by strenuous athletic activity.

### Claim 63 (depends on 60)

The method of claim 60, wherein pretreatment with periodic acceleration improves athletic performance by preconditioning a body tissue of the athlete.

### Claim 64 (depends on 60)

The method of claim 60, wherein pretreatment with periodic acceleration mitigates skeletal muscular cramps and/or helps prevent muscle strains during an athletic event.

### Claim 65 (depends on 60)

The method of claim 60, wherein pretreatment with periodic acceleration mitigates and/or helps prevent delayed onset muscular soreness (DOMS) and involuntary muscle cramps and spasms immediately following the athletic event and/or delayed until the sleeping hours.

### Claim 66 (depends on 60)

The method of claim 60, wherein pretreatment with periodic acceleration is used to treat exercise-induced bronchospasm in an athlete.

### Claim 67 (depends on 60)

The method of claim 60, wherein pretreatment with periodic acceleration helps to reduce and/or prevent susceptibility of athletes to viral and bacterial infections.

### Claim 68 (depends on 60)

The method of claim 60, wherein the pretreatment, treatment, and/or post-treatment with periodic acceleration treats or prevents cramps, aches, soreness, spasms, and other maladies brought on by exercise and/or other athletic activity.

### Claim 69 (depends on 57)

The method of claim 57, wherein treatment using periodic acceleration assists or replaces the use of corticosteroids and non-steriodal anti-inflammatory drugs (NSAIDs) in management of pain, injury, muscle soreness, strains, and contusions in athletes.

### Claim 70 (depends on 57)

The method of claim 57, wherein the provided periodic acceleration causes release of nitric oxide from the vascular endothelium of the subject through activation of endothelial nitric oxide synthase (eNOS) that in turn scavenges reactive oxygen species thereby diminishing or eliminating oxidative stress.

### Claim 71 (depends on 57)

The method of claim 57, wherein the periodic acceleration treats and/or prevents cramps, aches, soreness, spasms, and the like at least by diminishing any one of IL-1beta, IL-6, tumor necrosis factor or other inflammatory cytokines and adhesion molecules through suppression of the activity of inducible nitric oxide synthase (iNOS) caused by activation of endothelial nitric oxide synthase (eNOS) which is caused by release of nitric oxide from the vascular endothelium of the patient.

### Claim 72 (depends on 57)

The method of claim 57, wherein the periodic acceleration treats and/or prevents cramps, aches, soreness, spasms, and the like at least by diminishing any one of IL-1beta, IL-6, tumor necrosis factor or other inflammatory cytokines and adhesion molecules through suppression of nuclear factor kappa beta caused by activation of endothelial nitric oxide synthase (eNOS) which is caused by release of nitric oxide from the vascular endothelium of the patient.

### Claim 73 (depends on 67)

The method of claim 67, wherein treatments of periodic acceleration are used in weight control of the subject.

### Claim 74 (depends on 57)

The method of claim 57, wherein treatments of periodic acceleration are used to ameliorate metabolic syndrome, to improve sports performance, and/or to improve skeletal muscle pathology associated with the cachexia of COPD and cancers in weight control of the subject.

### Claim 75 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to promote ventricular remodeling.

### Claim 76 (depends on 75)

The method of claim 75, wherein periodic acceleration is combined with drugs that stabilize cardiac mast cells and/or cardiac drugs that activate eNOS.

### Claim 77 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat and/or prevent atrial fibrillation.

### Claim 78 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat and/or prevent complications from coronary bypass surgery.

### Claim 79 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat and/or prevent obstructive sleep apnea syndrome commonly observed in patients with coronary artery disease.

### Claim 80 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat and/or prevent cognitive deficits, learning deficits, and/or behavioral abnormalities in early cognitive impairment.

### Claim 81 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat and/or prevent Alzheimer's disease, vascular dementias, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's chorea, Wilson's disease, suprabulbar palsy, and/or Tourette syndrome.

### Claim 82 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat and/or prevent cardiac allograft vasculopathy.

### Claim 83 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to promote angiogenesis in ischemic tissues.

### Claim 84 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to manage hereditary hemorrhagic telangiectasia.

### Claim 85 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat and/or prevent migraine.

### Claim 86 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat the inflammation attendant with prion diseases.

### Claim 87 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to manage the aging process.

### Claim 88 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to manage Sjogren's syndrome.

### Claim 89 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to manage the chronic phase of Lyme disease.

### Claim 90 (depends on 89)

The method of claim 89, wherein periodic acceleration is combined with antibiotics.

### Claim 91 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat Gulf War syndrome.

### Claim 92 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to improve mucocilary clearance and surfactant production, and to minimize lung damage associated with usual positive pressure mechanical ventilation.

### Claim 93 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat patients who have corticosteroid resistance and asthma or corticosteroid resistance and inflammatory bowel disease.

### Claim 94 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat chronic otitis media.

### Claim 95 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to promote nail regeration.

### Claim 96 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to in conjunction with cell free hemoglobin transfusion in order to treat and/or prevent a nitric oxide deficit.

### Claim 97 (depends on 57)

The method of claim 57, wherein periodic acceleration is used to treat radiation injuries.
